JEFFERY A SMISEK
CIK 1193038 · Chairman, President & CEO · last filed 2024-06-10
JEFFERY A SMISEK is a Chairman, President & CEO who has filed 48 SEC Form 4 insider transactions across 4 companies since 2007. Across all open-market trades the lifetime net is +$2.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $63.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$63.60M
4
48
$2.52M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Director | 43,020 | $7.30 | $314.0K | $1.47M | 6 | 2024-05-24 |
| NOV | Director | 45,804 | $20.70 | $948.1K | -$596.5K | 16 | 2015-05-14 |
| UAL | Chairman, President & CEO | 490,030 | $123.76 | $60.65M | $1.64M | 21 | 2015-03-03 |
| CAL | President | 138,502 | $14.47 | $2.00M | $0 | 1 | 2008-01-08 |
Recent Filings
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-10 | — | Gift (G) | −767 | $0 | |
| 2024-05-24 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Gift (G) | −3,750 | $0 | EDGAR |
| 2024-03-29 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Sell (S) | −8,242 | -$21.2K | EDGAR |
| 2024-03-28 | — | Notice (144) | −8,242 | -$23.9K | EDGAR |
| 2023-11-27 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Sell (S) | −1,470 | -$5.4K | EDGAR |
| 2023-11-22 | — | Notice (144) | −1,470 | -$5.6K | EDGAR |
| 2023-06-09 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-25 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Mixed | +1,694,541 | $1.50M | EDGAR |
| 2015-05-14 | NOV | Grant (A) | +3,374 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.